Even patients with a 5-year risk for major vascular events <10% may benefit from primary prevention using statin therapy, according to the results of a large meta-analysis. This study may hold particular significance for patients in India, where genetic susceptibility results in a higher rate of vascular events, and where…
Read more »
Elevated plasma homocysteine levels (hyperhomocysteinemia) are increasingly considered to be an important marker for cardiovascular disease (CVD), especially in Indians. The relevance of this finding is highlighted by reports that suggest mortality attributable to CVD is rising in India—and is expected to continue to rise—by 103% in men and by…
Read more »
Most doctors know that identifying and treating patients with vascular disease can be difficult. A recent meta-analysis found that measuring inter-arm blood pressures can help you determine which patients are at greater risk for vascular disease or death. Patients with a large inter-arm SBP difference need a vascular assessment, because…
Read more »
indicates a Peer-Reviewed Article
Statin benefits in primary prevention outweigh risk of diabetes
The benefit of preventing vascular events outweighs the increased risk of new-onset diabetes in patients without cardiovascular disease but with an elevated level of high-sensitivity C-reactive protein (hs-CRP), researchers have found. India is the country with the greatest number of diabetes patients in the world, according to the International Diabetes…
Read more »